ImmunoPrecise Antibodies
Quarterly Financials
| Values in thousands | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
Revenue | $4,090 | $4,165 | $3,169 | $6,787 |
Gross Profit | 2,423 | 2,688 | 1,531 | 4,233 |
EBITDA | -3,400 | -3,016 | -3,245 | -957 |
EBIT | -3,614 | -3,225 | -4,190 | -1,845 |
Net Income | -3,865 | -3,226 | -2,966 | -2,101 |
Net Change In Cash | 4,090 | 4,165 | 3,169 | 6,787 |
Free Cash Flow | -2,955 | -2,944 | -4,495 | -1,499 |
Cash | 14,181 | 16,508 | 4,897 | 10,665 |
Basic Shares | 46,515 | 46,156 | 39,637 | 33,118 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $24,309 | $24,812 | $21,173 | $19,803 |
Gross Profit | 11,500 | 9,194 | 7,324 | 9,173 |
EBITDA | -28,888 | -23,224 | -21,554 | -12,265 |
EBIT | -33,963 | -29,028 | -28,403 | -16,120 |
Net Income | -29,974 | -26,428 | -27,213 | -17,087 |
Net Change In Cash | 24,309 | 24,812 | 21,173 | 19,803 |
Free Cash Flow | -7,209 | -5,643 | -21,328 | -11,178 |
Cash | 10,665 | 3,459 | 8,280 | 29,965 |
Basic Shares | 33,385 | 25,636 | 24,897 | 19,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-01-31 | -$0.05 |
2025-10-31 | -$0.07 |
2025-07-31 | -$0.09 |
2025-04-30 | -$0.05 |
